Kontour (Xi'an) Medical Technology Co (688314) Fair Value & Analysis
Healthcare · CN · Market cap 3.3B CNY
Analysis
Kontour (Xi'an) Medical Technology Co (688314) currently trades at ¥37.12, while our model-based Fair Value estimate is ¥26.76 — implying the stock looks roughly 27.9% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Kontour (Xi'an) Medical Technology Co., Ltd. engages in the research and development, production, and sale of Class III implantable medical devices in China. The company offers products in the fields of neurosurgery cranial repair and fixation, cardiothoracic surgery sternum fixation, and maxillofacial repair. It also provides oral bone repair materials, oral absorbable biofilm, implant system, and other tools. In addition, the company offers repair and fixation products that include traditional titanium materials, high-end PEEK materials, and absorbent polymer materials; PEEK4D bioactive plates; PEEK bone plates, titanium mesh plates, PEEK link plates, PEEK screws, titanium link plates, test molds, bone plugs, bone mesh, bone plug strips, disposable brain drainage devices, supporting surgical tools, and other complete products for skull repair and fixation surgery process. Kontour (Xi'an) Medical Technology Co., Ltd. was founded in 2005 and is based in Xi'an, China.
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.